Home Science & Technology A recent discovery could lead to new treatments

A recent discovery could lead to new treatments


Parkinson’s disease is a brain disorder that causes involuntary or uncontrolled movements, including tremors, stiffness, and problems with balance and coordination.

Scientists are taking the next step in understanding the role it plays in the disease.

Currently, there are no modifying therapies for Parkinson’s disease that could change the course of the disease. Researchers from University of Colorado Anschutz Medical Campus is leading a group of experts from around the world trying to change that.

They recently published a new study in the journal Brain that brings scientists one step closer to understanding an important protein called α-synuclein (αSyn), which they found links inflammation and Parkinson’s disease.

The αSyn protein is mainly expressed in neurons and has been linked to neurodegenerative diseases such as Parkinson’s disease and dementia with Lewy bodies. This new study identifies a novel mechanism linking interferon activation and αSyn function in neurons as a possible trigger for the development of Parkinson’s disease.

“It is critical to further understand the triggers that contribute to the development of Parkinson’s disease and how inflammation may interact with proteins found in the disease. With this information, we can potentially provide new treatment approaches by altering or interfering with these inflammatory pathways that may serve as triggers for disease,” said David Beckham, MD, associate professor of infectious diseases at the University of Colorado. School of Medicine – Located on the CU Anschutz Medical Campus.

To investigate the mechanism of αSyn-induced immune responses to viral infections in the brain, researchers challenged αSyn knockout (KO) mice and human αSyn KO dopaminergic neurons[{” attribute=””>RNA virus infection. They discovered that αSyn is required for neuronal expression of interferon-stimulated genes (ISGs). They then found that following any stimulus that triggers interferon signals, a type of immune response, αSyn interacts with signaling proteins in neurons to trigger the expression of ISGs.

This study establishes the first clear link between inflammation and αSyn, a protein connected to the development of Parkinson’s disease.

The scientists state that these findings demonstrate that αSyn responds to infection and inflammatory pathways and that this connection may have a crucial role in the development of Parkinson’s disease. The next critical step is to see whether interactions between interferon and αSyn result in the formation of toxic forms of misfolded αSyn known as fibrils, which have been found in Parkinson’s disease.

The researchers suggest future studies are needed to look into the interactions between type 1 interferon signals in neurons and misfolded αSyn to determine if drugs that inhibit these interactions can prevent the formation of misfolded αSyn. This would result in a potentially disease-modifying therapeutic approach that is needed for patients.

Reference: “Alpha-synuclein supports type 1 interferon signalling in neurons and brain tissue” by Brendan Monogue, Yixi Chen, Hadrian Sparks, Ranya Behbehani, Andrew Chai, Alexander J Rajic, Aaron Massey, B K Kleinschmidt-Demasters, Matthieu Vermeren, Tilo Kunath and J David Beckham, 21 July 2022, Brain.
DOI: 10.1093/brain/awac192

Previous articleApple Watch Ultra: Everything you need to know
Next articleNRDC to Congress: Don’t pass a pollution measure that controls car emissions